PeHub -- Great Lakes Pharmaceuticals Inc., a Cleveland-based developer of an antimicrobial catheter lock solution, has raised $3.1 million in Series B funding. Charter Life Sciences led the round, and was joined by Early Stage Partners and return backers Everett Partners, Ohio TechAngel Fund and North Coast Angel Fund.
